An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1

Broadly HIV-1-neutralizing antibodies (BnAbs) display one or more unusual traits, including a long heavy chain complementarity-determining region 3 (HCDR3), polyreactivity, and high levels of somatic mutations. These shared characteristics suggest that BnAb development might be limited by immune tol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2014-04, Vol.124 (4), p.1835-1843
Hauptverfasser: Bonsignori, Mattia, Wiehe, Kevin, Grimm, Sebastian K, Lynch, Rebecca, Yang, Guang, Kozink, Daniel M, Perrin, Florence, Cooper, Abby J, Hwang, Kwan-Ki, Chen, Xi, Liu, Mengfei, McKee, Krisha, Parks, Robert J, Eudailey, Joshua, Wang, Minyue, Clowse, Megan, Criscione-Schreiber, Lisa G, Moody, M Anthony, Ackerman, Margaret E, Boyd, Scott D, Gao, Feng, Kelsoe, Garnett, Verkoczy, Laurent, Tomaras, Georgia D, Liao, Hua-Xin, Kepler, Thomas B, Montefiori, David C, Mascola, John R, Haynes, Barton F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Broadly HIV-1-neutralizing antibodies (BnAbs) display one or more unusual traits, including a long heavy chain complementarity-determining region 3 (HCDR3), polyreactivity, and high levels of somatic mutations. These shared characteristics suggest that BnAb development might be limited by immune tolerance controls. It has been postulated that HIV-1-infected individuals with autoimmune disease and defective immune tolerance mechanisms may produce BnAbs more readily than those without autoimmune diseases. In this study, we identified an HIV-1-infected individual with SLE who exhibited controlled viral load (
ISSN:0021-9738
1558-8238
DOI:10.1172/JCI73441